Topical Cyclosporine in Oral Lichen Planus—A Series of 21 Open-Label, Biphasic, Single-Patient Observations

Topical cyclosporine (CSA) has been reported as an alternative treatment in steroid-refractory oral lichen planus (OLP), but evidence is limited and conflicting. An N-of-1 trial setting could be appropriate to evaluate interindividual differences in treatment response. We studied a series of 21 open...

Descripción completa

Detalles Bibliográficos
Autores principales: Monshi, Babak, Ellersdorfer, Christina, Edelmayer, Michael, Dvorak, Gabriella, Ganger, Clemens, Ulm, Christian, Rappersberger, Klemens, Vujic, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622196/
https://www.ncbi.nlm.nih.gov/pubmed/34830736
http://dx.doi.org/10.3390/jcm10225454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622196/
https://www.ncbi.nlm.nih.gov/pubmed/34830736
http://dx.doi.org/10.3390/jcm10225454

Ejemplares similares